Studies: ACT-FASTERID TrialNIS-ODE-FAS-2009/1Clinicaltrials.gov identifierNCT01171417DescriptionAn epidemiological prospective cohort study to describe treatment patterns of fulvestrant and exernestane in postmenopausal patients with advanced HR+ breast cancer under real-life conditions in Germany StatusactiveDisease
SponsorAstraZenecaTinsdaler Weg 183 22880 Wedel Germany Coordinating investigatorNo dataPrincipal investigator
Study nurse
|
|